The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.
about
The impact of biological interventions for ulcerative colitis on health-related quality of lifeThe impact of biological interventions for ulcerative colitis on health-related quality of lifeEfficacy and Safety of Adalimumab in Moderately to Severely Active Cases of Ulcerative Colitis: A Meta-Analysis of Published Placebo-Controlled TrialsThe Role of Laboratory Tests in Crohn's DiseaseTherapeutic drug monitoring in patients with inflammatory bowel diseaseImmunology of inflammatory bowel disease and molecular targets for biologics.Alexithymia and personality traits of patients with inflammatory bowel disease.Disease impact on the quality of life of children with inflammatory bowel disease.Health-related quality of life in patients with inflammatory bowel disease: a single-center experience.Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis.Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease.Health outcomes and cost-effectiveness of certolizumab pegol in the treatment of Crohn's disease.Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI).Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease.JAK inhibition in inflammatory bowel disease.Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.Adalimumab in ulcerative colitis - efficacy, safety and optimization in the era of treat-to target.Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases.Physical fitness and physical activity in fatigued and non-fatigued inflammatory bowel disease patients.Effect of intestinal resection on quality of life in Crohn's disease.Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy.
P2860
Q24187078-20FFFB54-A2D7-4C96-BE8F-6E66757A3133Q24202509-933B5286-04EE-44D4-83FE-75A010A9C0E0Q28070298-9EDEF474-BDC7-403F-BA77-FD029572D4C8Q28075045-09751935-ACD6-475C-8025-0F7F4D4DF1A2Q35140715-BCB7F197-BD4C-49EE-BAD1-992B18C9A5FCQ35222593-B8ABC907-3AC3-47BF-8891-3CA294243028Q37620621-D235E9E4-5879-451E-96BA-22C0C2EAE6ECQ37643994-CEF520F4-1BB0-4638-A481-54AE976056D7Q37647443-23C46586-6819-4A47-9720-704500B0C5D6Q38186069-14EFAE4A-CF01-4C7F-BA9F-12346392479CQ38205873-32864602-11D0-4B8C-96E4-845BD5E814B2Q38248218-5BFA79CE-DDA2-4ED0-B041-F7274822FD02Q38430984-2FDC4257-9824-44ED-A7A0-5EF9EC59CCA1Q38435506-FF913ED5-67D8-4C0F-B81D-91007F780C63Q38454062-8C1E4040-A914-4A47-90A1-557FD6A6995BQ38673082-A0BCFB11-311B-4913-BE00-B72BA729D066Q38761142-50B7BCFA-00CA-4A23-B5D8-2AD7C37DF254Q38822920-C5501CCB-29C6-4DE1-9C60-327A5497B09EQ38895960-3DE4EB15-D210-4589-A8E3-2681A4EA206DQ39293951-C1A13F1A-E652-4A41-9BB7-F3108F4AECE7Q47830387-61AB77DD-C554-4198-9BCC-738CEDFCF4A2Q48038691-E9DFC081-3C1F-40BD-BE56-7A0EAC269F8EQ48041364-24509DD2-1FE6-4CF9-9C15-36B7B762A31AQ48106537-5E75E837-373E-4913-96C3-BBDE727CDA24
P2860
The impact of biologics on health-related quality of life in patients with inflammatory bowel disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The impact of biologics on hea ...... th inflammatory bowel disease.
@ast
The impact of biologics on hea ...... th inflammatory bowel disease.
@en
type
label
The impact of biologics on hea ...... th inflammatory bowel disease.
@ast
The impact of biologics on hea ...... th inflammatory bowel disease.
@en
prefLabel
The impact of biologics on hea ...... th inflammatory bowel disease.
@ast
The impact of biologics on hea ...... th inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
The impact of biologics on hea ...... th inflammatory bowel disease.
@en
P2093
Adriaan Van't Spijker
C Janneke van der Woude
Lauran Vogelaar
P2860
P304
P356
10.2147/CEG.S4512
P407
P577
2009-09-25T00:00:00Z